ACADIA PHARMACEUTICALS A/S: Financial statements 2012
CVR: 19670694
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK -258,034. Equity in the 2012 report amounted to DKK -9,801.
- Profit/Loss
- DKK -258,034
- Equity
- DKK -9,801
- Total Assets
- DKK 4,484
Official annual report
Keep an eye on ACADIA PHARMACEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.